Search results
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance Canada· 6 days agoThe most recent trading session ended with AbbVie (ABBV) standing at $170.75, reflecting a -1.15%...
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Zacks via Yahoo Finance Canada· 4 days agoFollowing the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to...
AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Zacks via Yahoo Finance Canada· 3 days agoAbbVie's (ABBV) acquisition of Celsius Therapeutics is set to add the latter's lead pipeline...
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
Zacks via Yahoo Finance Canada· 4 days agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could...
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance Canada· 7 days agoThe fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech...
US FDA rejects AbbVie's Parkinson's disease therapy for the second time
Reuters via Yahoo Canada News· 6 days agoAbbVie added the FDA had not identified issues with the therapy's safety or efficacy and did not...
AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
Zacks via Yahoo Finance Canada· 5 days agoAbbVie (ABBV) issues the second CRL for Parkinson's disease medicine, ABBV-951, based on some...
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
Simply Wall St. via Yahoo Finance Canada· 3 days agoThe fact that multiple AbbVie Inc. (NYSE:ABBV) insiders offloaded a considerable amount of shares...
AbbVie Parkinson’s Drug Rejected by FDA After Plant Inspection
Bloomberg· 6 days agoAbbVie Inc. failed to win approval for a new Parkinson’s disease drug after US regulators found...
Dollar General Corp (DG-N) Quote - Press Release
The Globe and Mail· 6 days agoIf you're looking to pump up your passive income stream, there are a handful of high-yield dividend stocks that deserve your attention. AbbVie(NYSE: ABBV), Ares Capital(NASDAQ ...
